Clinical Trials Browser

Hearing Loss × Head & Neck × 1 year × Clear all

NCT07407582 2026-04-13

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

Phase 1/2 Not yet recruiting

GenitourinaryHead & Neck

Head and Neck Neoplasms, Neoplasms, Testicular Neoplasms, Hearing Loss

NCT04915183 2026-03-09

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

NCT05789316 2026-01-12

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Phase NA Completed

Ototoxicity, Head and Neck Neoplasms, Hearing Loss

NCT06303180 2025-11-14

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

Head and Neck Neoplasms, Hearing Disorders, Laryngeal Diseases, Speech, Hearing Loss